The study addresses a long-standing unmet need for wearable technology to facilitate the accurate diagnosis of high blood pressure and early detection of preeclampsia, a leading cause of complications and mortality during pregnancy

这项研究解决了长期以来对可穿戴技术的未满足需求，以促进高血压的准确诊断和先兆子痫的早期发现，先兆子痫是妊娠期并发症和死亡的主要原因

NEW YORK, Feb. 20, 2024 /PRNewswire/ -- Dynocardia, developer of ViTrack, the first-of-its-kind non-invasive, wearable blood pressure (BP) and heart monitor, and NYC Health + Hospitals, the nation's largest safety net health system, are partnering on a study of hypertensive diseases of pregnancy (HDP).

纽约，2024年2月20日/PRNewswire/--ViTrack（第一款无创可穿戴血压（BP）和心脏监护仪）的开发商Dynocardia，以及美国最大的安全网健康系统纽约健康+医院，正在合作进行妊娠高血压疾病（HDP）的研究。

The study will include at least 150 women who are pregnant or have recently given birth. The perinatal study addresses a long-standing unmet need for accurate and continuous BP for reliable diagnosis of HDP and for prediction and early detection of preeclampsia. The research is being funded by a $2.3M grant from the National Institute of Health's National Heart, Lung, and Blood Institute (NHLBI)..

这项研究将包括至少150名怀孕或最近分娩的女性。围产期研究解决了长期以来未满足的对准确和连续血压的需求，以可靠地诊断HDP以及预测和早期发现先兆子痫。这项研究由美国国立卫生研究院国家心肺血液研究所（NHLBI）提供230万美元的资助。。

HDP, a constellation of high BP disorders that may occur during pregnancy, affects both the mother and the child and is a leading cause of pregnancy-related complications and death globally. While the risks posed by HDP have doubled over the past decade in the United States, the effects on the maternal population are not evenly distributed.

HDP是妊娠期间可能发生的一系列高血压疾病，影响母亲和孩子，是全球妊娠相关并发症和死亡的主要原因。虽然HDP在美国造成的风险在过去十年中翻了一番，但对孕产妇的影响并不是均匀分布的。

African American women are at 5 times the risk from eclampsia and preeclampsia, which are severe forms of HDP that can impair the liver and kidneys, trigger strokes, and even result in death. Over the last 3 years, this risk has been exacerbated by the COVID-19 (coronavirus disease) pandemic, as evidenced by the increased incidence and severity of preeclampsia and an associated increase in preterm births and stillbirths..

非洲裔美国女性患子痫和先兆子痫的风险是其5倍，子痫和先兆子痫是HDP的严重形式，可损害肝脏和肾脏，引发中风，甚至导致死亡。在过去的3年中，COVID-19（冠状病毒病）大流行加剧了这种风险，先兆子痫的发病率和严重程度增加以及早产和死产的相关增加证明了这一点。。

Automatic arm-cuff devices, currently the standard of care for monitoring BP, have two significant limitations: inaccuracy and the lack of continuous measurement capability. As a result, incorrect diagnoses of hypertension occur at a staggering rate of 30%. Moreover, pregnant women are even more vulnerable to these errors due to hemodynamic and vascular changes that occur during pregnancy..

自动臂套装置是目前监测血压的标准护理设备，有两个显着的局限性：不准确和缺乏连续测量能力。因此，高血压的错误诊断发生率高达30%。此外，由于怀孕期间发生的血流动力学和血管变化，孕妇更容易出现这些错误。。

ViTrack is a one-of-a-kind blood pressure monitoring device that stands out from all other existing devices. It uses a unique combination of computer vision and artificial intelligence to accurately measure both systolic and diastolic blood pressures on a beat-to-beat basis without the need for external calibration.

ViTrack是一种独一无二的血压监测设备，从所有其他现有设备中脱颖而出。它使用计算机视觉和人工智能的独特组合，可以逐搏准确测量收缩压和舒张压，而无需外部校准。

Furthermore, ViTrack can perform these measurements regardless of patient movement or wrist position relative to the heart, which eliminates the impact of hydrostatic pressure changes..

此外，无论患者的运动或手腕相对于心脏的位置如何，ViTrack都可以进行这些测量，从而消除了静水压力变化的影响。。

The NHLBI has provided funding for a study that aims to evaluate the effectiveness of ViTrack in diagnosing HDP accurately and quickly. Additionally, the study intends to determine if ViTrack can provide precise measurements of 24-hour BP profiles for prediction purposes. This could lead to a meaningful improvement in patient care and management..

NHLBI为一项旨在评估ViTrack在准确快速诊断HDP方面的有效性的研究提供了资金。此外，该研究旨在确定ViTrack是否可以为预测目的提供24小时血压曲线的精确测量。这可能会导致患者护理和管理方面的有意义的改进。。

'Hypertensive disorders of pregnancy pose a growing threat to pregnant women, especially among Black patients and other patients of color who bear a disproportionate burden of maternal mortality and severe maternal morbidity,' said Wendy Wilcox, MD, Chief Women's Health Officer at NYC Health + Hospitals. 'After an extensive review, the NHLBI selected ViTrack to address this challenge.

纽约市健康+医院首席女性健康官温迪·威尔科克斯医学博士说：“妊娠期高血压疾病对孕妇构成越来越大的威胁，尤其是黑人患者和其他有色人种患者，他们承受着不成比例的孕产妇死亡率和严重的孕产妇发病率负担。”。经过广泛审查，NHLBI选择了ViTrack来应对这一挑战。

We're excited about the potential to mitigate risk among the women who rely on us for their prenatal care.'.

我们很高兴有可能减轻依赖我们进行产前护理的女性的风险。”。

There is an urgent need for continuous and accurate real-world data for the prediction and early detection of preeclampsia.

迫切需要连续准确的现实世界数据来预测和早期发现先兆子痫。

'We're thrilled to have a new tool that will enable us to identify subtle hemodynamic and vascular changes that can predict extreme fluctuations in blood pressure that may pose a threat to pregnant women,' said Daryl Wieland, MD, Chair of OB-GYN at NYC Health + Hospitals/Jacobi|NCB.

纽约市健康+医院/雅各比NCB妇产科主任DarylWieland医学博士说：“我们很高兴有一种新工具，可以识别细微的血流动力学和血管变化，这些变化可以预测可能对孕妇构成威胁的血压极端波动。”。

'ViTrack technology offers a new and unprecedented ability to continuously measure blood pressure and other critical heart and respiratory data, to enable predictive monitoring for early diagnosis and management of preeclampsia, and to prevent prenatal and postpartum complications,' said Kecia Gaither, MD, Director of Perinatal Services and Maternal-Fetal Medicine at NYC Health + Hospitals/Lincoln..

医学博士凯西亚·盖瑟（KeciaGaither）说：“ViTrack技术提供了一种前所未有的新能力，可以连续测量血压和其他关键的心脏和呼吸数据，为先兆子痫的早期诊断和管理提供预测性监测，并预防产前和产后并发症。”，纽约健康+医院/林肯围产期服务和母胎医学主任。。

'We are truly grateful to the NHLBI for their continued support and this initial opportunity to partner with NYC H+H,' said Mohan Thanikachalam, MD, cardiac surgeon and CEO of Dynocardia. Groundbreaking BP monitoring with ViTrack technology has the power to transform lives across the world. 'We recognize the crucial role of accurate and continuous blood pressure monitoring in ensuring optimal care during pregnancy, especially among African American women.

心脏外科医生兼Dynocardia首席执行官MohanThanikachalam医学博士说：“我们非常感谢NHLBI的持续支持以及与纽约H+H合作的最初机会。”。利用ViTrack技术进行的开创性BP监测有能力改变世界各地的生活。”我们认识到准确和持续的血压监测在确保怀孕期间最佳护理方面的关键作用，特别是在非裔美国女性中。

Given the known challenges of HDP, we believe that the implementation of ViTrack technology can significantly contribute to safeguarding and promoting the well-being of all expectant mothers.'.

鉴于HDP面临的已知挑战，我们认为ViTrack技术的实施可以为保障和促进所有孕妇的福祉做出重大贡献。”。

Please visit www.dynocardia.com for more information.

有关更多信息，请访问www.dynocardia.com。

About Dynocardia

关于Dynocardia

Dynocardia is a biomedical device development company committed to satisfying critical unmet needs to improve healthcare worldwide. ViTrack®, the company's lead diagnostic device, is powered by proprietary technology, making it a first-of-its-kind, cuff-less device that allows for continuous, non-invasive blood pressure measurement.

Dynocardia是一家生物医学设备开发公司，致力于满足关键的未满足需求，以改善全球医疗保健。该公司的领先诊断设备ViTrack®采用专有技术，是同类产品中第一款无袖带设备，可进行连续、无创血压测量。

Unlike conventional occlusive cuff BP devices, ViTrack is a cuff-less wrist-wearable, connected, comfortable and easy-to-use device that offers direct, beat-to-beat measurement of systolic and diastolic BPs with accuracy and continuity comparable to intra-arterial lines. ViTrack, with data-rich capability that includes BP, heart rate, respiratory, and advanced heart function parameters, is poised to be a cornerstone of predictive medicine.

与传统的闭塞性袖带血压装置不同，ViTrack是一种无袖带的手腕可穿戴，连接，舒适且易于使用的装置，可直接逐搏测量收缩压和舒张压，其准确性和连续性与动脉内线相当。ViTrack具有丰富的数据功能，包括血压，心率，呼吸和高级心脏功能参数，有望成为预测医学的基石。

For more information, visit www.dynocardia.com and LinkedIn..

有关更多信息，请访问www.dynocardia.com和LinkedIn。。

About NYC Health + Hospitals

关于纽约健康+医院

NYC Health + Hospitals is the largest municipal health care system in the nation serving more than a million New Yorkers annually in more than 70 patient care locations across the city's five boroughs. A robust network of outpatient, neighborhood-based primary and specialty care centers anchors care coordination with the system's trauma centers, nursing homes, post-acute care centers, home care agency, and MetroPlus health plan—all supported by 11 essential hospitals.

纽约市健康+医院是全国最大的市级医疗保健系统，每年在纽约市五个区的70多个病人护理地点为100多万纽约人提供服务。一个强大的门诊、社区初级和专科护理中心网络，与该系统的创伤中心、疗养院、急性后护理中心、家庭护理机构和大都会健康计划进行护理协调，所有这些都得到了11家基本医院的支持。

Its diverse workforce of more than 43,000 employees is uniquely focused on empowering New Yorkers, without exception, to live the healthiest life possible. For more information, visit www.nychealthandhospitals.org and stay connected on Facebook, Twitter, Instagram and LinkedIn..

它拥有43000多名员工，拥有多样化的员工队伍，专注于让纽约人无一例外地过上尽可能健康的生活。有关更多信息，请访问www.nychealthandhathes.org，并在Facebook、Twitter、Instagram和LinkedIn上保持联系。。

Media Contact:Alan RothenbergGlue Advertising and Public Relations[email protected]917 885 7530

媒体联系人：Alan RothenbergGlue广告与公共关系[受电子邮件保护]917 885 7530

SOURCE Dynocardia

源性心动过速